Stigningen i specificiteten fra prækontrastforstærket til kombineret præ - og postkontrastforstærket scanning var 9% i lever- studiet (patient- baseret analyse), mens der ikke var nogen stigning i specificiteten i nyre- studiet (patient- baseret analyse samt læsions- baseret analyse).
The increase in specificity from precontrast to combined pre and postcontrast MRI was 9% in the liver study (patient based analysis) while there was no increase in specificity in the kidney study (patient-based analysis as well as lesion-based analysis).